News

News Image 1 Copy Seb Option3

Several Medical Device Consultancy Firms Acquired by Veranex

Medical technology company Vernaex, has recently acquired a portfdolio of full service medical device consultancy companies, which provide regulatory and clinical affairs, biocompatibility services and quality assurance for medical devices, as well as IVD (in vitro diagnostic) devices.

Based within Sweden, this portfolio is comprised of Devicia, which is a full service partner which offers clinical expertise, Claryin, which is a provider of strategic guidance for quality assurance and strategic affairs, and also the affiliated companies Lea Reg, Kickfile and Limulus Bio.

Along with a recent acquisition of Medidee, based in Switzerland, these companies mark an expansion of Veranex’sa European reach, building clinical, quality service and regulatory segments. This particularly strengthens Veranex’s MDR (medical device regulation) and IVDR (in vitro diagnostic regulation) strategies, and adds expertise within biological evaluation, as well as software for medical devices, while also expanding their infrastructure, designating more local representation within the EU and the UK, with the ecosystem of companies adding 3 further locations across Europe and the United States to Veranex’s global footprint.

Veranex CEO David Dockhorn said: “This group of companies, led by Devicia and Clarvin, shares the same goal as Veranex: working with our clients to achieve and accelerate medtech innovation. Devicia, Clarvin, and their affiliate companies all focus exclusively on medical devices and IVD, providing strategic guidance and informed execution across a number of areas, including clinical trial, medical writing, regulatory strategies, toxicology assessments, designated local representation, and system technologies that bolster Veranex’s full-service medtech capabilities and solutions.”

Devicia CEO Elisabeth Liljensten said: “We are extremely excited about the opportunity to support clients even more comprehensively with our full-service medical device and IVD services, and a significantly stronger global presence. We strongly believe that a global perspective and broad geographic footprint provides strategic value to market access for our clients.”

Clarvin CEO Åsa Runnäs added: “Since the first interaction with Veranex, we realised we shared the same vision for the best way to help our clients — with a combination of top regulatory intelligence, expert knowledge within different areas, and true global reach.” Veranex’s Financial advisor were A&M (Alvarez and Marsal), and the company’s legal advisor was firm MWE (McDermott Will & Emery). Financial details are not currently being disclosed

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Globus Medical obtains FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe